16th Annual King & Spalding Medical Device Summit
Register for the 16th Annual King & Spalding Medical Device Summit in Chicago!
Legal
Learn more about our Legal work.
Amicus Briefs
AdvaMed submits amicus briefs on a variety of topics because of the strong interest and relevance to the medtech industry.
Shining a Light On Litigation Financing: A Good First Step From GAO
Chris White, AdvaMed’s General Counsel, explores the GAO’s recent report as “a welcome independent review raising attention to the need for disclosure and regulation of the litigation financing that fuels…
AdvaMed Comments on the FTC’s Proposed Rule Banning Non-Compete Clauses in Contracts with Workers
AdvaMed, the medtech association, recently commented on the FTC’s proposed rule that would ban employers from imposing or enforcing non-compete clauses in contracts with certain workers. AdvaMed opposes the FTC’s vastly…
FTC’s Non-Compete Agreement Rulemaking Puts Medtech Innovation and Patient Access to New Treatments at Risk
The Federal Trade Commission published a proposed rule in the Federal Register that would, among other things, prohibit employers from imposing non-compete agreements on their employees.
AdvaMed Asks Supreme Court to Protect Innovation in False Claims Act Case
AdvaMed, the medtech association, asked the Supreme Court to affirm the judgments of the court of appeals in the Seventh Circuit in a significant case concerning the False Claims Act…
AdvaMed’s Medical Innovation Agenda for the 118th Congress
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
AdvaMed Comment Letter to OIG – January 27, 2023
AdvaMed responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
AdvaMed Asks U.S. Supreme Court to Review Arbitrary and Excessive Punishments Resulting From Lack of Clarity in State Law
The Advanced Medical Technology Association (AdvaMed) asked the U.S. Supreme Court to review and reverse a California appeals court’s decision imposing over $300 million in penalties on a medical device…
AdvaMed Asks U.S. Supreme Court to Affirm Government’s Authority to Dismiss Qui Tam Suits
The Advanced Medical Technology Association (AdvaMed) has asked the U.S. Supreme Court to affirm a Third Circuit decision that confirms the government’s right to dismiss qui tam suits under the…